Financial Statements/ESG Information - [Interim/Half-Year Report]

Fangzhou Inc. operates as an online chronic disease management platform. The Company provides chronic disease management. Fangzhou provides its services in China.

2025 Interim Report

(Headlines Revised) Announcements and Notices - [Unusual Price/Turnover Movements - Qualified]

Announcement Made Pursuant To Rule 13.10 Of The Listing Rules

Announcements and Notices - [Unusual Price/Turnover Movements - Standard or Super]

Announcements and Notices - [Interim Results]

Interim Results Announcement For The Six Months Ended June 30, 2025

Announcements and Notices - [Date of Board Meeting]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Fangzhou (6086 HK)

2025 Interim Report

Announcement Made Pursuant To Rule 13.10 Of The Listing Rules

Announcement Made Pursuant To Rule 13.10 Of The Listing Rules

Interim Results Announcement For The Six Months Ended June 30, 2025

Date Of Board Meeting

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)